
Tandem Diabetes Care, Inc.
Free shipping on orders over $99 · 30-day returns
Control-IQ+ technology is an FDA 510(k)-cleared medical device (K260429) manufactured by Tandem Diabetes Care, Inc.. This device is classified under the Clinical Chemistry specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on April 23, 2026. Regulation: 8.